Cargando…

Immunogenicity and protective efficacy of a pan-fungal vaccine in preclinical models of aspergillosis, candidiasis, and pneumocystosis

Invasive fungal infections cause over 1.5 million deaths worldwide. Despite increases in fungal infections as well as the numbers of individuals at risk, there are no clinically approved fungal vaccines. We produced a “pan-fungal” peptide, NXT-2, based on a previously identified vaccine candidate an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rayens, Emily, Rabacal, Whitney, Willems, Hubertine M E, Kirton, Gabrielle M, Barber, James P, Mousa, Jarrod J, Celia-Sanchez, Brandi N, Momany, Michelle, Norris, Karen A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Biological, Health, and Medical Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802316/ https://www.ncbi.nlm.nih.gov/pubmed/36712332 http://dx.doi.org/10.1093/pnasnexus/pgac248

Ejemplares similares

Vaccine-Induced Protection in Two Murine Models of Invasive Pulmonary Aspergillosis
por: Rayens, Emily, et al.
Publicado: (2021)

The lung microbiome in patients with pneumocystosis
por: Kehrmann, J., et al.
Publicado: (2017)

Pneumocystosis in a lurcher puppy
por: Giannoulopoulos, George, et al.
Publicado: (2020)

Gaining an Understanding of Pneumocystosis in Wales
por: Ayling-Smith, Jonathan, et al.
Publicado: (2023)

Immunization with Pneumocystis recombinant KEX1 induces robust and durable humoral responses in immunocompromised non-human primates
por: Cobos Jiménez, Viviana, et al.
Publicado: (2019)

Contribution of the qPCR for the Diagnosis of Pneumocystosis
por: Issa, Nahema, et al.
Publicado: (2017)

Oculosystemic pneumocystosis in 2 sibling Chihuahuas
por: Johnson, Lynelle R., et al.
Publicado: (2023)

Vulvovaginal Candidiasis: A Current Understanding and Burning Questions
por: Willems, Hubertine M. E., et al.
Publicado: (2020)

A therapeutic vaccine strategy to prevent Pneumocystis pneumonia in an immunocompromised host in a non-human primate model of HIV and Pneumocystis co-infection
por: Rabacal, Whitney, et al.
Publicado: (2022)

Micafungin in the treatment of invasive candidiasis and invasive aspergillosis
por: Wiederhold, Nathan P, et al.
Publicado: (2009)

Genetic polymorphisms associated with treatment failure and mortality in pediatric Pneumocystosis
por: Singh, Yogita, et al.
Publicado: (2019)

Prevalence of Pneumocystosis in Sub-Saharan Africa and Helminth Immune Modulation
por: Fonte, Luis, et al.
Publicado: (2021)

COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave
por: Bretagne, Stéphane, et al.
Publicado: (2021)

Statin treatment prevents the development of pulmonary arterial hypertension in a nonhuman primate model of HIV-associated PAH
por: Rabacal, Whitney, et al.
Publicado: (2019)

Safety, Efficacy, and Exposure–Response of Voriconazole in Pediatric Patients With Invasive Aspergillosis, Invasive Candidiasis or Esophageal Candidiasis
por: Martin, Judith M., et al.
Publicado: (2017)

The rise in cases of mucormycosis, candidiasis and aspergillosis amidst COVID19
por: Ghosh, Asmita, et al.
Publicado: (2021)

Invasive Aspergillosis and Candidiasis in a Patient with Plasma Cell Myeloma
por: Khadwal, Alka, et al.
Publicado: (2023)

Epidemiological characteristics of pulmonary pneumocystosis and concurrent infections in pigs in Jeju Island, Korea
por: Kim, Ki-Seung, et al.
Publicado: (2011)

COVID-19–related Respiratory Failure and Lymphopenia Do Not Seem Associated with Pneumocystosis
por: Blaize, Marion, et al.
Publicado: (2020)

Serological diagnosis of pneumocystosis: production of a synthetic recombinant antigen for immunodetection of Pneumocystis jirovecii
por: Tomás, A. L., et al.
Publicado: (2016)

Invasive pulmonary aspergillosis and candidiasis in a critically ill patient with COVID-19
por: Benedetti, María Fernanda, et al.
Publicado: (2022)

Efficacy of Rezafungin in Prophylactic Mouse Models of Invasive Candidiasis, Aspergillosis, and Pneumocystis Pneumonia
por: Miesel, Lynn, et al.
Publicado: (2021)

Nanomaterial-Based Antifungal Therapies to Combat Fungal Diseases Aspergillosis, Coccidioidomycosis, Mucormycosis, and Candidiasis
por: León-Buitimea, Angel, et al.
Publicado: (2021)

Reply to Blaize et al.: COVID-19–related Respiratory Failure and Lymphopenia Do Not Seem Associated with Pneumocystosis
por: Menon, Aravind A., et al.
Publicado: (2020)

Risk of pneumocystosis after early discontinuation of prophylaxis among HIV-infected patients receiving highly active antiretroviral therapy
por: Cheng, Chien-Yu, et al.
Publicado: (2010)

Sporulation environment drives phenotypic variation in the pathogen Aspergillus fumigatus
por: Earl Kang, S, et al.
Publicado: (2021)

A Pan-Pneumovirus vaccine based on immunodominant epitopes of the fusion protein
por: Huang, Jiachen, et al.
Publicado: (2022)

A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis
por: Kohno, S., et al.
Publicado: (2012)

Rezafungin treatment in mouse models of invasive candidiasis and aspergillosis: Insights on the PK/PD pharmacometrics of rezafungin efficacy
por: Miesel, Lynn, et al.
Publicado: (2019)

Demographic and Socioeconomic Factors Associated with Fungal Infection Risk, United States, 2019
por: Rayens, Emily, et al.
Publicado: (2022)

Next-Generation Influenza HA Immunogens and Adjuvants in Pursuit of a Broadly Protective Vaccine
por: Nagashima, Kaito A., et al.
Publicado: (2021)

Application of DNA amplification to pneumocystosis: presence of serum Pneumocystis carinii DNA during human and experimentally induced Pneumocystis carinii pneumonia
Publicado: (1992)

Pneumocystosis as a Complication of H1N1 Influenza A Infection in an HIV-Positive Patient on Effective cART
por: Franconi, Iacopo, et al.
Publicado: (2019)

Multiple drugs: Acute kidney injury due to drug interaction, Pneumocystis jiroveci Pneumocystosis and off-label use: case report
Publicado: (2021)

Analysis of Cyp51 protein sequences shows 4 major Cyp51 gene family groups across fungi
por: Celia-Sanchez, Brandi N, et al.
Publicado: (2022)

A variant ECE1 allele contributes to reduced pathogenicity of Candida albicans during vulvovaginal candidiasis
por: Liu, Junyan, et al.
Publicado: (2021)

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
por: Tissot, Frederic, et al.
Publicado: (2017)

Invasive pulmonary aspergillosis with candidiasis: usefulness of molecular and ultrastructural morphological analysis on FFPE tissue for invasive fungal infections
por: Kubota, Yusaku, et al.
Publicado: (2023)

In silico prediction of Gallibacterium anatis pan-immunogens
por: Bager, Ragnhild J, et al.
Publicado: (2014)

Prevalence and Healthcare Burden of Fungal Infections in the United States, 2018
por: Rayens, Emily, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_orjdkahqmgvdahfsqdno9d281e